Home » Topics » Musculoskeletal, BioWorld Science

Musculoskeletal, BioWorld Science
RSS

Study confirms nonsedative effects of Neurana's skeletal muscle relaxant tolperisone

Oct. 27, 2017

Regentis Biomaterials identifies new conjugates for bone disorders

Oct. 27, 2017

FDA grants fast track designation to MIV-711 for treatment of osteoarthritis

Oct. 25, 2017

New candidate prodrug TransCon CNP for treating achondroplasia shows promise

Oct. 25, 2017

FDA approves Simponi Aria for psoriatic arthritis and ankylosing spondylitis

Oct. 23, 2017

Novel griseofulvin derivatives discovered by Daiichi Sankyo

Oct. 18, 2017

FDA approves Zilretta for osteoarthritis knee pain

Oct. 9, 2017

DiscGenics cleared to begin clinical testing of IDCT in U.S.

Oct. 4, 2017

FDA grants rare pediatric disease and fast track designations to Audentes' AT-132

Sep. 28, 2017

Acer Therapeutics reports results from pivotal study of Edsivo in vascular Ehlers-Danlos syndrome

Sep. 27, 2017

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...